Mosaic Family Wealth, LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 179 filers reported holding CRISPR THERAPEUTICS AG in Q2 2018. The put-call ratio across all filers is 3.04 and the average weighting 0.7%.

Quarter-by-quarter ownership
Mosaic Family Wealth, LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q1 2019$18,000
+28.6%
4950.0%0.01%
+16.7%
Q4 2018$14,000
-22.2%
4950.0%0.01%
-14.3%
Q3 2018$18,000
-37.9%
4950.0%0.01%
-36.4%
Q2 2018$29,000
+26.1%
4950.0%0.01%
+22.2%
Q1 2018$23,000
+91.7%
4950.0%0.01%
+125.0%
Q4 2017$12,000
+33.3%
4950.0%0.00%
+33.3%
Q3 2017$9,000
+12.5%
4950.0%0.00%0.0%
Q2 2017$8,000
-27.3%
4950.0%0.00%
-40.0%
Q1 2017$11,0004950.01%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q2 2018
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,608,874$160,053,562,00054.44%
Abingworth LLP 1,237,202$54,858,00032.62%
NEA Management Company, LLC 2,090,678$92,722,0004.00%
New Leaf Venture Partners, L.L.C. 444,708$19,723,0003.59%
EcoR1 Capital, LLC 500,000$22,175,0002.00%
ARK Investment Management 1,453,590$64,467,0001.95%
CLOUGH CAPITAL PARTNERS L P 337,731$14,978,0001.41%
Casdin Capital, LLC 220,000$9,757,0001.19%
Valiant Capital Management, L.P. 271,700$12,050,0001.07%
Monashee Investment Management LLC 110,000$4,879,0001.03%
View complete list of CRISPR THERAPEUTICS AG shareholders